Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 2—February 2011

Research

Severe Cases of Pandemic (H1N1) 2009 in Children, Germany

Mathias AltmannComments to Author , Lena Fiebig, Jana Soyka, Rüdiger von Kries, Manuel Dehnert, and Walter Haas
Author affiliations: Author affiliations: Robert Koch Institute, Berlin, Germany (M. Altmann, L. Fiebig, J. Soyka, M. Dehnert, W. Haas); Ludwig-Maximilians-Universität, Munich, Germany (R. von Kries)

Main Article

Table 4

Treatment administered to children with severe pandemic (H1N1) 2009, Germany, 2009–2010*

Survivors Nonsurvivors Subtotal p value OR (95% CI)
Oseltamivir 53/88 (60) 2/4 (50) 44/74 (59) 7/10 (70) 51/84 (61) 0.733 1.6 (0.3–10.2)
Antimicrobial drug 80/91 (88) 4/4 (100) 67/77 (87) 9/10 (90) 76/87 (87) 1 1.3 (0.2–64.7)
Catecholamine 28/85 (33) 0/4 (0) 20/70 (29) 8/11 (73) 28/81 (35) 0.007 6.7 (1.4–41.8)
Mechanical ventilation 56/90 (62) 0/4 (0) 45/75 (60) 11/11 (100) 56/86 (65) 0.007 NA (1.8–NA)

*Values are no. positive/no with available information (%) except as indicated. PICU, pediatric intensive care unit; OR, odds ratio; CI, confidence interval, NA, not applicable.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO